Clinical Trial Update: Adult Congenital Heart Disease Registry (QuERI)

View source ↗

Summary

The Adult Congenital Heart Disease Registry (QuERI) trial sponsored by Actelion focusing on Pulmonary Arterial Hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Snippet

Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Status: COMPLETED